Explore the dynamic growth of the viscosupplementation market, projected to reach USD 5.26 billion by 2030. This report delves into market trends, key drivers, and regional insights shaping the industry.
The global viscosupplementation market is experiencing significant growth, driven by the increasing prevalence of osteoarthritis and the rising demand for minimally invasive treatments. In 2024, the market was valued at approximately USD 3.25 billion and is projected to reach USD 5.26 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.4% from 2025 to 2030.
This surge is attributed to advancements in medical technology, improved patient outcomes, and a shift towards non-surgical interventions. Viscosupplementation, primarily involving the injection of hyaluronic acid into the joint space, aims to restore the rheological properties of synovial fluid, thereby alleviating pain and improving joint function
Rising Incidence of Osteoarthritis: The aging global population and lifestyle factors contribute to the increasing cases of osteoarthritis, particularly in weight-bearing joints like the knee.
Preference for Non-Surgical Treatments: Patients and healthcare providers are favoring non-invasive procedures over traditional surgical options due to shorter recovery times and reduced risks.
Technological Advancements: Innovations in hyaluronic acid formulations and injection techniques have enhanced the efficacy and safety profiles of viscosupplementation therapies.
North America dominates the market due to high healthcare expenditure, advanced medical infrastructure, and a large patient pool. Europe experiences steady growth, supported by favorable reimbursement policies and increasing awareness of joint health. APAC is emerging as a lucrative market with rising healthcare investments, an aging population, and growing acceptance of advanced medical treatments. While currently smaller markets, Latin America and the Middle East & Africa present significant growth opportunities due to improving healthcare access and infrastructure.
The viscosupplementation market is characterized by the presence of several key players, including Anika Therapeutics, Seikagaku Corporation, and Fidia Farmaceutici. These companies are focusing on strategic initiatives such as mergers, acquisitions, and product innovations to strengthen their market position. Additionally, the development of biosimilar and non-animal-derived hyaluronic acid products is gaining momentum, catering to the growing demand for ethical and sustainable treatment options.
The viscosupplementation market is poised for continued growth, driven by technological advancements, increasing patient demand for non-surgical treatments, and expanding applications beyond knee osteoarthritis. However, addressing challenges related to cost, regulation, and competition will be crucial for sustained market expansion.
AWS Marketplace now accepts line of credit payments through the PNC Vendor Finance program. This program is available to select AWS customers in the US, excluding NV, NC, ND, TN, & VT.
This listing offers one pricing option: Product Access, measured in units. It grants subscribers access to the market research report at no cost. There are no separate tiers, sizes, or usage add-ons to compare. You gain access through this single dimension. After access is confirmed, the report is delivered digitally, typically as a downloadable file sent by email within 24 to 48 hours.
Top-of-mind questions for buyers
What does one unit of Product Access give me?
One unit grants a subscriber access to the market research report. Access is the single billable dimension, and it carries no charge. Once your access is confirmed, you receive the report digitally, usually as a downloadable file sent to your registered email within 24 to 48 hours.
In what format is the report delivered after I gain access?
Reports are delivered in digital formats such as PDF, Excel, or Word. You receive them by email or through a download link. If you request a printed copy, it is couriered within three working days from the date payment is received.
Can I get a refund or cancel after receiving the report?
No. All sales are final, and the vendor does not offer money-back guarantees. Because reports are delivered digitally with sensitive research data, cancellations, returns, and refunds are not accepted once a report is sold and delivered. Review the terms carefully before purchasing.
www.nextmsc.com+1
Helpful?
Vendor refund policy
All sales are final; no refunds or returns are accepted. Our reports include sensitive, researched data from various sources, including industry experts and paid services. We ensure confidentiality and offer customization at an additional cost. Please review our terms before purchase. For inquiries, contact customer service.
How can we make this page better?
Tell us how we can improve this page, or report an issue with this product.
Give us feedbackReport a problem with this product or seller
Legal
Vendor terms and conditions
Upon subscribing to this product, you must acknowledge and agree to the terms and conditions outlined in the vendor's End User License Agreement (EULA).
Content disclaimer
Vendors are responsible for their product descriptions and other product content. AWS does not warrant that vendors' product descriptions or other product content are accurate, complete, reliable, current, or error-free.
60-minute live analyst briefing focused on the Viscosupplementation Market. Gain actionable market intelligence, orthopedic treatment insights, and AWS-aligned recommendations to optimize procurement strategy, digital healthcare initiatives, product innovation, and cloud infrastructure planning.